Press Releases

May 16 -	Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013
Apr 30 -	Immunovaccine Announces Results of 2013 Annual General Meeting
Apr 16 -	Immunovaccine Receives Financial Contribution from the Government of Canada to Provide Support towards Clinical Studies in Common Respiratory Illness Affecting Both Children and the Elderly
Mar 28 -	Immunovaccine Announces 2012 Year-End Results
Mar 5 -	Immunovaccine Closes Private Placement Financing at $1.6 Million
Feb 27 -	Immunovaccine Provides Update on Private Placement Financing
Feb 6 -	Immunovaccine Announces Financing Plans
Feb 5 -	Immunovaccine Announces a Proposed Equity Offering
Jan 30 -	Immunovaccine Signs Agreement for Phase I/II Clinical Trial of DPX-0907 in Breast and Ovarian Cancer Patients
Jan 7 -	Immunovaccine’s DPX-Survivac Produces Sustained, Dose Related Immune Responses in Phase I Ovarian Cancer Study
Jan 3 -	Immunovaccine Reports Positive Results from Ongoing Study of DepoVax™-Based Anthrax Vaccines